Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis | Zendy

Christoph Roderburg | Zendy; Frank Tacke | Zendy; Christian Trautwein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis

Author(s) -

Christoph Roderburg,

Frank Tacke,

Christian Trautwein

Publication year - 2016

Publication title -

visceral medicine

Language(s) - English

Resource type - Journals

eISSN - 2297-475X

pISSN - 2297-4725

DOI - 10.1159/000444990

Subject(s) - hepatocellular carcinoma , medicine , hepatitis b , hepatitis b virus , viral hepatitis , hepatitis c , antiviral therapy , hepatitis c virus , gastroenterology , hepatitis d , immunology , virus , chronic hepatitis , hbsag

Chronic hepatitis B and C infections represent major risk factors for the development of hepatocellular carcinoma (HCC). Recently, the management of patients with viral hepatitis has dramatically changed. In the present review we discuss the impact of these developments on the prevention of HCC as well as the treatment of patients with HCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research